{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T18:13:28Z","timestamp":1793470408577,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013421","name":"Pink Ribbon Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013421","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006219","name":"Kurt Weill Foundation for Music","doi-asserted-by":"publisher","award":["EMCR 2016-8179"],"award-info":[{"award-number":["EMCR 2016-8179"]}],"id":[{"id":"10.13039\/100006219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006219","name":"Kurt Weill Foundation for Music","doi-asserted-by":"publisher","award":["2011-WO38"],"award-info":[{"award-number":["2011-WO38"]}],"id":[{"id":"10.13039\/100006219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006219","name":"Kurt Weill Foundation for Music","doi-asserted-by":"publisher","award":["C87"],"award-info":[{"award-number":["C87"]}],"id":[{"id":"10.13039\/100006219","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.breast.2025.104562","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:47:34Z","timestamp":1755650854000},"page":"104562","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Early prediction of menopausal status after chemotherapy in women with early breast cancer in order to optimize adjuvant endocrine therapy"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8966-2948","authenticated-orcid":false,"given":"Charissa","family":"van Zwol-Janssens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandy M.","family":"van Rosmalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Oomen-de Hoop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan C.","family":"Drooger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemieke","family":"van der Padt-Pruijsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanneke J.M.","family":"Zuetenhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne V.","family":"Louwers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny A.","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joop S.E.","family":"Laven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Jager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2025.104562_bib1","series-title":"Borstkanker in Nederland - kerncijfers uit de Nederlandse kankerregistratie","first-page":"2024","year":"2023"},{"key":"10.1016\/j.breast.2025.104562_bib2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrc721","article-title":"Endocrine-responsive breast cancer and strategies for combating resistance","volume":"2","author":"Ali","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.breast.2025.104562_bib3","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1200\/JCO.2016.67.1487","article-title":"Endocrine therapy for hormone receptor-positive metastatic breast cancer: American society of clinical oncology guideline","volume":"34","author":"Rugo","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2025.104562_bib4","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","article-title":"Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials","volume":"365","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.breast.2025.104562_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2025.105057","article-title":"Extended adjuvant endocrine therapy in early breast cancer: finding the individual balance","volume":"10","author":"Lobo-Martins","year":"2025","journal-title":"ESMO Open"},{"key":"10.1016\/j.breast.2025.104562_bib6","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1200\/JCO.22.01064","article-title":"Adjuvant exemestane with ovarian suppression in premenopausal breast cancer: long-term Follow-Up of the combined TEXT and SOFT trials","volume":"41","author":"Pagani","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2025.104562_bib7","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1200\/JCO.22.01065","article-title":"Adjuvant endocrine therapy in premenopausal breast cancer: 12-year results from SOFT","volume":"41","author":"Prudence","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2025.104562_bib8","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJMra000471","article-title":"Production and actions of estrogens","volume":"346","author":"Gruber","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.breast.2025.104562_bib9","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0959-8049(02)00810-9","article-title":"The use of gonadotrophin-releasing hormone (GnRH) agonists in early and advanced breast cancer in pre- and perimenopausal women","volume":"39","author":"Robertson","year":"2003","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.breast.2025.104562_bib10","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1200\/OP-24-00502","article-title":"Clinical management of ovarian function suppression in premenopausal women with breast cancer: a survey of members of ASCO","volume":"21","author":"Kelly","year":"2025","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.breast.2025.104562_bib11","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/00042192-200111000-00004","article-title":"Executive summary: stages of reproductive aging workshop (STRAW) park city, Utah, July","volume":"8","author":"Soules","year":"2001","journal-title":"Menopause"},{"key":"10.1016\/j.breast.2025.104562_bib12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/2053369116648270","article-title":"Diagnosis of perimenopause and menopause (section 5)","volume":"22","author":"Hillard","year":"2016","journal-title":"Post Reprod Health"},{"key":"10.1016\/j.breast.2025.104562_bib13","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.fertnstert.2015.11.020","article-title":"Menses resumption after cancer treatment-induced amenorrhea occurs early or not at all","volume":"105","author":"Jacobson","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.breast.2025.104562_bib14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/humupd\/dmac004","article-title":"Anti-mullerian hormone as a marker of ovarian reserve and premature ovarian insufficiency in children and women with cancer: a systematic review","volume":"28","author":"Anderson","year":"2022","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.breast.2025.104562_bib15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4103\/tjem.tjem_182_23","article-title":"Receiver operating characteristic curve analysis in diagnostic accuracy studies: a guide to interpreting the area under the curve value","volume":"23","author":"Corbacioglu","year":"2023","journal-title":"Turk J Emerg Med"},{"key":"10.1016\/j.breast.2025.104562_bib16","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s10549-018-4997-2","article-title":"Pretreatment Anti-Mullerian hormone-based nomogram predicts menstruation status after chemotherapy for premenopausal women with hormone receptor-positive early breast cancer","volume":"173","author":"Xue","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2025.104562_bib17","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1186\/s12885-017-3593-x","article-title":"Reduced ovarian reserve in young early breast cancer patients: preliminary data from a prospective cohort trial","volume":"17","author":"Wenners","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.breast.2025.104562_bib18","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1002\/ijc.33933","article-title":"Is ovarian recovery after chemotherapy in young patients with early breast cancer influenced by controlled ovarian hyperstimulation for fertility preservation or tumor characteristics? Results of a prospective study in 126 patients","volume":"150","author":"Mailliez","year":"2022","journal-title":"Int J Cancer"},{"key":"10.1016\/j.breast.2025.104562_bib19","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/annonc\/mdx184","article-title":"GnRH agonist for protection against ovarian toxicity during chemotherapy for early breast cancer: the anglo Celtic group OPTION trial","volume":"28","author":"Leonard","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.breast.2025.104562_bib20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejca.2021.04.038","article-title":"Chemotherapy-induced ovarian failure in young women with early breast cancer: prospective analysis of four randomised neoadjuvant\/adjuvant breast cancer trials","volume":"152","author":"Furlanetto","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.breast.2025.104562_bib21","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1016\/j.ejca.2013.07.014","article-title":"Pretreatment Anti-M\u00fcllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer","volume":"49","author":"Anderson","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.breast.2025.104562_bib22","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejca.2017.10.001","article-title":"The utility of Anti-M\u00fcllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer","volume":"87","author":"Anderson","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.breast.2025.104562_bib23","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13048-015-0209-4","article-title":"Age, Anti-mullerian hormone, antral follicles count to predict amenorrhea or oligomenorrhea after chemotherapy with cyclophosphamide","volume":"8","author":"D'Avila","year":"2015","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.breast.2025.104562_bib24","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1210\/jc.2010-2582","article-title":"Pretreatment serum anti-m\u00fcllerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer","volume":"96","author":"Anderson","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.breast.2025.104562_bib25","doi-asserted-by":"crossref","first-page":"e3714","DOI":"10.1210\/clinem\/dgac370","article-title":"Comparison of 3 different AMH assays with AMH levels and follicle count in women with polycystic ovary syndrome","volume":"107","author":"Moolhuijsen","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.breast.2025.104562_bib26","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejogrb.2017.04.029","article-title":"Age-independent anti-Mullerian hormone (AMH) standard deviation scores to estimate ovarian function","volume":"213","author":"Helden","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.breast.2025.104562_bib27","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.fertnstert.2020.09.134","article-title":"Testing and interpreting measures of ovarian reserve: a committee opinion","volume":"114","author":"Penzias","year":"2020","journal-title":"Fertil Steril"},{"key":"10.1016\/j.breast.2025.104562_bib28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.maturitas.2020.03.002","article-title":"Anti-m\u00fcllerian hormone levels and risk of cancer: a systematic review","volume":"135","author":"Verdiesen","year":"2020","journal-title":"Maturitas"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096097762500579X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096097762500579X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T10:00:29Z","timestamp":1772877629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096097762500579X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":28,"alternative-id":["S096097762500579X"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2025.104562","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early prediction of menopausal status after chemotherapy in women with early breast cancer in order to optimize adjuvant endocrine therapy","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2025.104562","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104562"}}